Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2 Psoriasis 1 Polycystic Ovary Syndrome 1 Osteoarthritis 1 Neoplasms 1 Esophageal Neoplasms 1 Cardiovascular Diseases 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

pembrolizumab 27 Oxaliplatin 24 Paclitaxel 22 Fluorouracil 21 Carboplatin 18 Leucovorin 16 Cisplatin 16 Capecitabine 16 Radiotherapy 15 Nivolumab 12 Drug Therapy 12 Radiation 10 Trastuzumab 9 Surgical Procedures, Operative 8 Immunotherapy 8 Magnetic Resonance Spectroscopy 7 Esophagectomy 7 Blood Specimen Collection 7 Taxes 6 tislelizumab 5 durvalumab 5 Surveys and Questionnaires 5 Specimen Handling 5 Radiotherapy, Intensity-Modulated 5 Irinotecan 5 Immune Checkpoint Inhibitors 5 Docetaxel 5 Bevacizumab 5 Ramucirumab 4 Fluorodeoxyglucose F18 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Fatty Acids, Omega-3 × 1 year × Clear all

NCT07272382 2025-12-09

ESO-Shanghai28

Fudan University

Phase NA Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡